Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,746.00    68.00 (1.85%)
Bid:
3,716.00
Ask:
3,754.00
Spread: 38.00 (1.023%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Update on Current Trading

16 Jun 2020 07:00

RNS Number : 0272Q
4imprint Group PLC
16 June 2020
 

16 June 2020

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

4imprint today provides a further update on the effect of the COVID-19 pandemic on the Group's trading and operations.

 

In our last COVID-19 update issued on 7 April 2020, we noted that the spread of the pandemic and associated 'Safer at Home' or similar directives had resulted in order counts reducing to about 20% of prior year level. As the partial or full lifting of these restrictions began in many US states in May and early June, weekly order counts have steadily increased and are now approaching 50% of the 2019 comparative. Importantly, we continue to acquire new customers and the new-to-existing customer ratio has remained broadly stable over this period.

 

Since the beginning of the pandemic, we have continued to provide excellent service to our customers through an expanded 'work from home' capability. Our two US locations in Oshkosh, Wisconsin and our office in Manchester, UK have now reopened. Where practical, however, team members continue to work from home, allowing us to implement robust social distancing protocols in our facilities. In line with our culture, the health, safety and wellbeing of our people remains our top priority, and we have continued to prioritise the retention of our team members throughout this difficult period. Our team is ready and very motivated to service the recovering demand that we are seeing.

 

Cash conservation was a clear focus for the Group early in the COVID-19 crisis. Action has been taken to control discretionary and capital spend. We executed a thoughtful and effective recalibration of the marketing strategy to significantly decrease marketing investment throughout the period yet stay connected with our existing customers and maintain our brand awareness. This strategy has also given us the flexibility to ramp up the marketing as justified by market conditions.

 

The Group's balance sheet and liquidity position remain strong. At the end of May 2020, the Group had cash balances of $28.1m, and no debt. This is after the payment in May of the $9.4m planned lump sum contribution to the Group's defined benefit pension plan. We also have a working capital facility of $20m.

 

The Group intends to announce its half year results for the 26 weeks ended 27 June 2020 on Thursday 13 August 2020. In the meantime, the Board remains confident in 4imprint's strategy, business model and market position, culminating in the delivery of longer-term value for all stakeholders.

 

 

 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

MHP Communications

Tel. + 44 (0) 20 3128 8100

 

Kevin Lyons-Tarr

Chief Executive Officer

 

David Seekings

Chief Financial Officer

Katie Hunt

 

 

Rachel Mann

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFSFWIESSEFM
Date   Source Headline
8th Nov 20077:00 amRNSHolding(s) in Company
7th Nov 20077:00 amRNSRule 8.3- 4imprint Group PLC
5th Nov 20074:12 pmRNSHolding(s) in Company
2nd Nov 20071:09 pmRNSHolding(s) in Company
1st Oct 20074:41 pmRNSSecond Price Monitoring Extn
1st Oct 20074:35 pmRNSPrice Monitoring Extension
21st Sep 20075:02 pmRNSHolding(s) in Company
19th Sep 200712:44 pmRNSHolding(s) in Company
10th Sep 20072:34 pmRNSDirector/PDMR Shareholding
4th Sep 20076:08 pmRNSHolding(s) in Company
20th Aug 20072:56 pmRNSHolding(s) in Company
16th Aug 20074:59 pmRNSHolding(s) in Company
15th Aug 20074:06 pmRNSHolding(s) in Company
7th Aug 200712:13 pmRNSHolding(s) in Company
2nd Aug 20072:34 pmRNSDirector/PDMR Shareholding
1st Aug 20079:43 amRNSHolding(s) in Company
31st Jul 20077:01 amRNSInterim Results
25th Jul 20072:53 pmRNSHolding(s) in Company
13th Jul 20077:00 amRNSHolding(s) in Company
11th Jul 20074:33 pmRNSHolding(s) in Company
9th Jul 20072:15 pmRNSHolding(s) in Company
12th Jun 20077:00 amRNSHolding(s) in Company
11th Jun 20075:18 pmRNSHolding(s) in Company
11th Jun 20075:09 pmRNSHolding(s) in Company
11th Jun 20074:48 pmRNSHolding(s) in Company
24th May 20076:27 pmRNSHolding(s) in Company
10th May 20076:29 pmRNSHolding(s) in Company
25th Apr 20075:52 pmRNSHolding(s) in Company
18th Apr 200711:00 amRNSAGM Statement
17th Apr 20071:29 pmRNSHolding(s) in Company
19th Mar 20073:16 pmRNSHolding(s) in Company
16th Mar 200712:40 pmRNSHolding(s) in Company
8th Mar 20075:07 pmRNSHolding(s) in Company
8th Mar 20077:00 amRNSHolding(s) in Company
27th Feb 20077:03 amRNSFinal Results
19th Feb 200712:39 pmRNSHolding(s) in Company
13th Feb 20079:54 amRNSHolding(s) in Company
8th Feb 200712:04 pmRNSAdditional Listing
5th Feb 200712:07 pmRNSHolding(s) in Company
2nd Feb 20074:27 pmRNSHolding(s) in Company
1st Feb 20077:00 amRNSHolding(s) in Company
24th Jan 20071:16 pmRNSHolding(s) in Company
17th Jan 20077:00 amRNSHolding(s) in Company
4th Jan 20077:00 amRNSHolding(s) in Company
22nd Dec 200610:18 amRNSHolding(s) in Company
21st Dec 20064:30 pmRNSTotal Voting Rights
28th Nov 20065:50 pmRNSAcquisition
27th Nov 200610:24 amRNSResult of EGM
17th Nov 20067:00 amRNSDirector/PDMR Shareholding
1st Nov 20067:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.